id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-0002-0048,FDA,FDA-2016-N-0002,"Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications
and 158 Abbreviated New Drug Applications; Correction",Notice,Correction,2018-02-13T05:00:00Z,2018,2,2018-02-13T05:00:00Z,,2018-02-13T15:05:16Z,2018-02926,0,0,0900006482f279da